Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0001493152-25-029594·Indaptus Therapeutics, Inc.
Schedule 13D ownership disclosure
INDAPTUS THERAPEUTICS INC
Common Stock, $0.01 par value per share · CUSIP: 45339J105
Event date: 2025-12-22
- Filing-level shares
- 273,103.00
- Percent of class
- 12.7%
- Jeffery A. MecklerReported CIK 0001506916
Shares: 273,103.00 · Class: 12.7%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001493152-25-029594
- Form type
- SCHEDULE 13D/A
- Filer
- Indaptus Therapeutics, Inc.
- CIK
- CIK 1857044
- Filed
- Dec 30, 2025
- Reporting period
- Dec 22, 2025
- Description
- Schedule 13D beneficial ownership